Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
3.420
-0.040 (-1.16%)
Feb 12, 2026, 1:43 PM EST - Market open
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $805.17 million as of February 12, 2026. Its market cap has increased by 109.57% in one year.
Market Cap
805.17M
Enterprise Value
1.32B
1-Year Change
109.57%
Ranking
Category
Stock Price
$3.42
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $805.17M, an increase of 294.50%. That is a compound annual growth rate of 11.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 827.20M | -6.48% |
| Dec 31, 2025 | 884.50M | 104.04% |
| Dec 31, 2024 | 433.50M | 27.50% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
| Jun 26, 2013 | 204.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amphastar Pharmaceuticals | 1.31B |
| Cronos Group | 1.01B |
| Pacira BioSciences | 906.46M |
| Tilray Brands | 897.10M |
| BioAge Labs | 856.34M |
| Ironwood Pharmaceuticals | 787.36M |
| Emergent BioSolutions | 579.30M |
| Organogenesis Holdings | 486.07M |